Skip to Content

Meet the Team

Everyone on our team is committed to working toward better treatment – and ultimately a cure – for HIV/AIDS. Get to know us a bit below:

Marlene Allen

Marlene Allen, Research Associate

Marlene has been the lab manager and regulatory manager for the site since 2000.

“I have always appreciated meeting and developing relationships with our study participants.”


Caitlyn Delgado

Caitlyn Delgado, Research Associate

Caitlyn joined the RCID research team in July of 2019 and has a desire to learn more about infectious disease and effective prevention strategies. As our research assistant, she helps the team with lab processing, chart preparation and data management, and assists with patient visits.

“I am honored to work with our community in a variety of ways to encourage HIV education, prevention and treatment. And along the way, I get to learn just as much as our patients!”

arlene has been the lab manager and regulatory manager for the site since 2000. “I have always appreciated meeting and developing relationships with our study participants.”

Lisa Dasnoit

Lisa Dasnoit, RN, BSN, Clinical Research Nurse II

Lisa has been with the Regional Center for Infectious Disease since 2016 as a Clinical Research Nurse II, and has eight years of HIV research experience. She coordinates and provides clinical care to research participants.

“This role is the perfect opportunity to provide support and education to those who need it most. I find the greatest satisfaction in seeing my patients taking an active role in their care.”

Kim Epperson

Kim Epperson, RN, BSN, Lead Clinical Research Coordinator

Kim manages the clinical operations of the research group and has been a member of the Infectious Disease Research team since 2004.

“The best part of my job is the relationships I have developed with all the study participants over the years and appreciating how much they have contributed to finding a cure for HIV!”

Danielle Guilbeault

Danielle Guilbeault, Research Assistant

Danielle recently joined the RCID research team in January of 2020 and is primarily working with data from the clinical trials. She looks forward to learning more about HIV, as well as treatments and prevention during the course of her time with RCID.

“I am very excited to be working in the clinic and I look forward to getting to know the research participants!”

Charles Hansen

Charles Hansen, MA, CCRC, Clinic Research Manager

Charles has been the Clinic Research Manager since 2017 and, prior to joining our team, he spent 35 years working in research-related positions, including serving as the Research Director for the AHEC/Graduate Medical Education programs in internal medicine, family medicine and pediatrics. He has provided research and administrative support for HIV-related clinical trials since 1980, and has maintained certification as a clinical research coordinator for 27 years.   

Laura Keck

Laura Keck, RN, Clinical Research Coordinator II

Laura joined the Regional Center for Infectious Disease in April of 2019 and has a decade of experience in clinical research, previously working at UNC’s Clinical and Translational Research Center and as a Clinical Research Specialist at UNC Dermatology.

“I am proud to serve the AIDS Clinical Trials Group, cooperatively promoting comprehensive and inclusive care.” 

Maria Stetson

Maria Stetson, Research Assistant

Maria serves as a Research Assistant with our group through the UNC Global HIV Prevention and Treatment Clinical Trials Unit, and has been in this role since November 2018. She provides support to sites at UNC Chapel Hill and the Regional Center for Infectious Disease in Greensboro, as well as international research sites in Vietnam, Malawi and Liberia. Maria currently assists with studies and helps with data quality control, lab processing and research recruitment. 

“The most rewarding aspect of this job is getting to know our incredible study participants. I consider it a privilege to hear their stories of resilience and to step alongside them in this journey towards better prevention, better treatments and a cure.”

Kees Van Dam

Kees Van Dam, MD, Principal Investigator

Dr. Van Dam earned his Bachelor of Arts degree from Duke University and his medical degree from the Medical College of Wisconsin. He attended the University of Utah for Internal Medicine Residency and the University of North Carolina at Chapel Hill for his Infectious Diseases Fellowship. Board certified in both Internal Medicine and Infectious Disease, he is an Assistant Professor at the University of North Carolina-AHEC. Dr. Van Dam is the Principal Investigator of all HIV clinical trials conducted at the Regional Center for Infectious Disease. A member of the Antiretroviral Therapy Transformative Science Group (TSG) of the AIDS Clinical Trials Group (ACTG) and the Less-Frequent-ART-Dosing Working Group of the ARTS TSG since 2016, Dr. Van Dam is particularly interested in novel treatments and novel mechanisms of delivery of antiretroviral therapy to patients.

In addition to overseeing research of the AIDS Clinical Trials Group as Site Leader, along with the HIV Prevention Trial Network Study 083, the INSIGHT Network Study Strategic Timing of Anti-Retrovirals (START) and several pharmaceutical-sponsored research endeavors, Dr. Van Dam has collaborated with Dr. Scott Rhodes, PhD, from Wake Forest University on Community-Based Research efforts such as “WeCare” and “We PrePARE.” Dr. Van Dam serves on the Board of Directors for Triad Health Project, one of the oldest AIDS Service Organizations in the country. He is highly involved within the community of those living with HIV and at risk for HIV infection. In addition to his strong interest in the science of HIV treatment and prevention, he is committed to addressing the social inequities and stigma that are one of the biggest obstacles to ending the HIV epidemic.

“I am passionate about being able to empower people living with HIV to gain control of their viruses with the miraculous drugs that we are so lucky to have so that they can resume living normal lives. I’m also very passionate about social justice within HIV. Stigma is still one of the most lethal components of this virus that we can otherwise very easily control.”